A new announcement from President Donald Trump and Health Secretary Robert F. Kennedy Jr. has set off a wave of controversy across the country. Speaking after a memorial event for Charlie Kirk, Trump hinted that “the biggest medical announcement in the history of the country” was on its way. The statement, paired with growing speculation, immediately drew nationwide attention as many waited to hear what the president had to say about rising autism rates in America.
At a press briefing, White House Press Secretary Karoline Leavitt confirmed that the president and RFK Jr. would deliver the news together. Reports quickly surfaced suggesting that the announcement would focus on a possible link between autism and the painkiller Tylenol, a claim that sparked heated debate before the conference even began. While Trump urged people to “keep an open mind,” critics warned against spreading unverified information that could cause unnecessary concern for families.
During the announcement, Trump referenced the dramatic rise in autism diagnoses over the past decades, saying that what was once considered rare has now become far more common. He suggested that health officials were advising pregnant women to be cautious with acetaminophen, Tylenol’s active ingredient. Trump went further, sharing his personal opinion that expectant mothers should avoid the drug entirely—remarks that immediately amplified the debate.
In response, Tylenol issued a strong statement denying any connection between its product and autism. The company emphasized that independent studies do not support such claims and expressed concern that misinformation could put pregnant women at greater risk if it discouraged them from safely treating pain and fever. As the controversy continues, experts stress the importance of relying on peer-reviewed science and official medical guidance rather than political statements or speculation.